A Safety and Efficacy Study of Infliximab (Remicade) in Patients With Plaque Type Psoriasis
Clinical trial NCT00230529 · COMPLETED
Trial details
- NCT number
- NCT00230529
- Sponsor
- Centocor, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Enrollment
- 249
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.